Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Mar 19;12(1):55-62.
doi: 10.4274/jcrpe.galenos.2019.2019.0048. Epub 2019 Aug 22.

Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program

Özlem Yayıcı Köken  1 , Cengiz Kara  2 , Gülay Can Yılmaz  3 , Hasan Murat Aydın  4
Affiliations
Comparative Study

Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program

Özlem Yayıcı Köken et al. J Clin Res Pediatr Endocrinol. .

Abstract

Objective: To determine the prevalence of obesity and metabolic syndrome (MetS) in children and adolescents with type 1 diabetes (T1D) and to compare the widely accepted and used diagnostic criteria for MetS established by the International Diabetes Federation (IDF), World Health Organisation (WHO) and National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII).

Methods: We conducted a descriptive, cross sectional study including T1D patients between 8-18 years of age. The three sets of criteria were used to determine the prevalence of MetS and findings compared. Risk factors related to MetS were extracted from hospital records.

Results: The study included 200 patients with T1D (52% boys). Of these, 18% (n=36) were overweight/obese (body mass index percentile ≥85%). MetS prevalence was 10.5%, 8.5% and 13.5% according to IDF, WHO and NCEP criteria, respectively. There were no statistically significant differences in age, gender, family history of T1D and T2D, pubertal stage, duration of diabetes, hemoglobin A1c levels and daily insulin doses between patients with or without MetS. In the overweight or obese T1D patients, the prevalence of MetS was 44.4%, 38.8% and 44.4% according to IDF, WHO and NCEP-ATPIII criteria, respectively.

Conclusion: Obesity prevalence in the T1D cohort was similar to that of the healthy population of the same age. Prevalence of MetS was higher in children and adolescents with T1D compared to the obese population in Turkey. The WHO criteria include microvascular complications which are rare in childhood and the NCEP criteria do not include a primary criterion while diagnosing non-obese patients according to waist circumference as MetS because the existence of diabetes is considered as a direct criterion. Our study suggests that IDF criteria which allows the diagnosis of MetS with obesity and have accepted criteria for the childhood are more suitable for the diagnosis of MetS in children and adolescents with T1D.

Keywords: prevalence; Type 1 diabetes; metabolic syndrome; double diabetes.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

Figures

Figure 1
Figure 1
The numbers of patients with metabolic syndrome diagnosis based on different diagnostic criteria IDF: International Diabetes Federation, WHO: World Health Organisation, NCEP-ATPIII: National Cholesterol Education Program-Adult Treatment Panel III
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Defronzo RA, Simonson D, Ferrannini E. Hepatic And Peripheral Insulin Resistance: A Common Feature Of Type 2 (Non-Insulin-Dependent) And Type 1 (Insulin-Dependent) Diabetes Mellitus. Diabetologia. 1982;23:313–319. - PubMed
    1. Teupe B, Bergis K. Epidemiological Evidence For “Double Diabetes”. Lancet. 1991;337:361–362. - PubMed
    1. No Authors List. Standards of Medical Care in Diabetes-2016: Summary of Revisions. Diabetes Care. 2017;40(Suppl 1):4–5. - PubMed
    1. Roglic G, Colhoun HM, Stevens LK, Lemkes HH, Manes C, Fuller JH. Parental History of Hypertension And Parental History of Diabetes and Microvascular Complications In Insulin-Dependent Diabetes Mellitus: The EURODIAB IDDM Complications Study. Diabet Med. 1998;15:418–426. - PubMed
    1. Bikhazi AB, Azar ST, Birbari AE, El-Zein GN, Haddad GE, Haddad RE, Bitar KM. Characterization of Insulin-Resistance: Role of Receptor Alteration In Insulin dependent Diabetes Mellitus, Essential Hypertension And Cardiac Hypertrophy. Eur J Pharm Sci. 2000;11:299–306. - PubMed

Publication types